Usman Khan
Usman Khan was appointed in a total of 18 companies and resigned from 1 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
British
Date of Birth
June 1979
Occupation
Accountant
Active
13
Resigned
1
Dissolved
4
Other
0
Total
18
Companies
| Company | Timeline | Status | |
| Opal Holdco 2 Limited Director • Director | 30 Apr 2025←5 Months→Current | Active | |
| Kymab Group Limited Director • Accountant | 1 Aug 2021←4 Years→Current | Active | |
| Kymab Limited Director • Accountant | 1 Aug 2021←4 Years→Current | Active | |
| Kiadis Pharma UK Limited Director • Accountant | 5 May 2021←8 Months→4 Jan 2022 | Dissolved | |
| Opella Healthcare UK Limited Director • Accountant | 31 Mar 2021←4 Years→Current | Active | |
| Genzyme Therapeutics Limited Director • Accountant | 31 Mar 2021←4 Years→Current | Active | |
| Aventis Pharma Holdings Limited Director • Accountant | 31 Mar 2021←4 Years→Current | Active | |
| Sanofi-Aventis UK Holdings Limited Director • Accountant | 31 Mar 2021←4 Years→Current | Active | |
| RPR (Us) Limited Director • Accountant | 31 Mar 2021←4 Years→Current | Active | |
| Hoechst Marion Roussel Limited Director • Accountant | 31 Mar 2021←1 Year 11 Months→14 Mar 2023 | Dissolved | |
Mutual People
- Gordon Michael TillettRPR (Us) Limited, Sanofi-Synthelabo UK Limited, Aventis Pharma Limited, and 10 more are mutual companies.
- Mr Francois-Xavier DuhaldeGenzyme Therapeutics Limited, Aventis Pharma Limited, Sanofi-Synthelabo UK Limited, and 9 more are mutual companies.
- Ms Jessamy Rachel BairdAcambis Research Limited, Sanofi-Synthelabo Limited, Sanofi-Aventis UK Holdings Limited, and 9 more are mutual companies.
- Michael James McClellanAventis Pharma Holdings Limited, Hoechst Marion Roussel Limited, May & Baker Limited, and 7 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
